$1.4 Billion is the total value of First Light Asset Management, LLC's 79 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 21.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPNE | Buy | SEASPINE HOLDINGS CORP | $88,612,000 | -10.1% | 6,506,038 | +3.9% | 6.35% | -2.2% |
| PRTA | Buy | PROTHENA CORPORATION PLC | $80,173,000 | -22.3% | 1,622,941 | +12.0% | 5.74% | -15.6% |
| MODN | Buy | MODEL N INC | $76,514,000 | -7.8% | 2,547,930 | +2.8% | 5.48% | +0.1% |
| ATRC | Buy | ATRICURE INC | $69,877,000 | +55.2% | 1,004,989 | +55.3% | 5.00% | +68.7% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $61,982,000 | +8.4% | 411,784 | -14.1% | 4.44% | +17.8% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLC | $60,918,000 | +99.9% | 1,000,783 | +36.6% | 4.36% | +117.2% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $60,791,000 | +1.1% | 1,511,843 | +2.3% | 4.35% | +9.9% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $60,025,000 | +56.0% | 645,848 | -0.0% | 4.30% | +69.6% |
| OMCL | Sell | OMNICELL INC | $55,015,000 | +4.7% | 304,895 | -13.9% | 3.94% | +13.8% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $47,578,000 | +43.9% | 680,170 | +7.4% | 3.41% | +56.4% |
| XENT | Sell | INTERSECT ENT INC | $46,368,000 | -20.2% | 1,697,834 | -20.5% | 3.32% | -13.3% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $36,903,000 | +9.4% | 281,701 | +2.2% | 2.64% | +18.9% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $34,587,000 | -13.1% | 411,313 | -6.8% | 2.48% | -5.5% |
| CDXS | Buy | CODEXIS INC | $34,058,000 | +109.3% | 1,089,150 | +55.7% | 2.44% | +127.5% |
| STRO | Buy | SUTRO BIOPHARMA INC | $33,429,000 | -19.2% | 2,246,588 | +2.5% | 2.39% | -12.2% |
| KROS | Buy | KEROS THERAPEUTICS INC | $32,303,000 | +371.4% | 552,098 | +218.7% | 2.31% | +412.9% |
| HCAT | Buy | HEALTH CATALYST INC | $32,213,000 | -19.0% | 813,046 | +2.3% | 2.31% | -11.9% |
| CDNA | Sell | CAREDX INC | $31,084,000 | -45.5% | 683,463 | -24.1% | 2.23% | -40.8% |
| MEIP | Buy | MEI PHARMA INC | $29,951,000 | +25.6% | 11,217,426 | +29.9% | 2.14% | +36.5% |
| CUTR | Sell | CUTERA INC | $27,142,000 | -24.2% | 656,873 | -14.6% | 1.94% | -17.6% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $26,580,000 | +22.9% | 2,325,485 | +31.0% | 1.90% | +33.5% |
| TPTX | Buy | TURNING POINT THERAPEUTICS | $26,217,000 | -12.9% | 549,626 | +21.4% | 1.88% | -5.3% |
| NEO | Sell | NEOGENOMICS INC | $26,065,000 | -48.8% | 763,907 | -27.7% | 1.87% | -44.4% |
| AXGN | Buy | AXOGEN INC | $21,414,000 | -39.5% | 2,285,373 | +2.1% | 1.53% | -34.2% |
| OPRX | Sell | OPTIMIZERX CORP | $19,488,000 | -55.1% | 313,769 | -38.2% | 1.40% | -51.2% |
| INSM | Sell | INSMED INC | $19,024,000 | -43.7% | 698,369 | -43.1% | 1.36% | -38.8% |
| BLU | New | BELLUS HEALTH INC | $18,729,000 | – | 2,326,528 | +100.0% | 1.34% | – |
| KRMD | Buy | REPRO-MED SYSTEMS INC | $16,542,000 | +7.3% | 5,514,106 | +2.0% | 1.18% | +16.6% |
| SIBN | Buy | SI-BONE INC | $15,997,000 | +5.8% | 720,243 | +2.1% | 1.15% | +15.1% |
| TEVA | Sell | TEVA PHARMACEUTICAL IND | $15,199,000 | -40.5% | 1,897,506 | -27.7% | 1.09% | -35.4% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $14,210,000 | -6.7% | 237,385 | +2.1% | 1.02% | +1.4% |
| New | PARAGON 28 INC | $12,787,000 | – | 722,841 | +100.0% | 0.92% | – | |
| Buy | MAXCYTE INC | $12,557,000 | +3.4% | 1,232,277 | +23.9% | 0.90% | +12.4% | |
| PFMT | Buy | PERFORMANT FINANCIAL CORPORATION | $11,776,000 | -33.0% | 4,886,173 | +10.1% | 0.84% | -27.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $11,290,000 | -17.3% | 127,785 | -27.6% | 0.81% | -10.0% |
| ITMR | Sell | ITAMAR MEDICAL LTD | $10,972,000 | -45.2% | 355,410 | -46.4% | 0.79% | -40.5% |
| NGM | New | NGM BIOPHARMACEUTICALS, INC | $10,111,000 | – | 570,898 | +100.0% | 0.72% | – |
| QDEL | Buy | QUIDEL CORP | $10,063,000 | -2.3% | 74,544 | +2.1% | 0.72% | +6.2% |
| PFE | Buy | PFIZER INC | $8,533,000 | +2244.2% | 144,497 | +1606.2% | 0.61% | +2445.8% |
| MRTX | New | MIRATI THERAPEUTICS INC | $8,071,000 | – | 55,024 | +100.0% | 0.58% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS INC | $7,750,000 | – | 272,796 | +100.0% | 0.56% | – |
| AXNX | Sell | AXONICS MODULATION TECHNOLOGIES | $7,602,000 | -65.8% | 135,752 | -60.3% | 0.54% | -62.9% |
| Buy | AKUMIN INC | $6,417,000 | -27.3% | 3,666,648 | +3.0% | 0.46% | -21.0% | |
| GMAB | Sell | GENMAB AS | $6,288,000 | -44.4% | 158,947 | -38.6% | 0.45% | -39.7% |
| SIEN | Buy | SIENTRA INC | $5,903,000 | -34.7% | 1,608,349 | +1.9% | 0.42% | -29.0% |
| ANNX | Sell | ANNEXON BIOSCIENCES INC | $5,443,000 | -39.5% | 473,700 | -2.1% | 0.39% | -34.2% |
| PLRX | New | PLIANT THERAPEUTICS, INC | $5,223,000 | – | 386,896 | +100.0% | 0.37% | – |
| ABCM | New | ABCAM PLC | $5,164,000 | – | 219,285 | +100.0% | 0.37% | – |
| NARI | Buy | INARI MEDICAL INC. | $4,066,000 | +327.1% | 44,547 | +279.6% | 0.29% | +361.9% |
| MRVI | Sell | MARAVAI LIFE SCIENCES | $4,049,000 | -30.5% | 96,637 | -18.6% | 0.29% | -24.5% |
| JYNT | Sell | THE JOINT CORP | $3,643,000 | -33.1% | 55,452 | -0.1% | 0.26% | -27.3% |
| SLP | Sell | SIMULATIONS PLUS INC | $3,549,000 | +19.6% | 75,023 | -0.1% | 0.25% | +30.3% |
| MIRO | Buy | MIROMATRIX MEDICAL INC | $2,289,000 | -30.8% | 488,092 | +2.8% | 0.16% | -24.8% |
| LHCG | Sell | LHC GROUP INC | $2,089,000 | -12.7% | 15,219 | -0.3% | 0.15% | -5.1% |
| AVTR | AVANTOR INC | $615,000 | +3.0% | 14,596 | 0.0% | 0.04% | +12.8% | |
| SYNH | SYNEOS HEALTH INC CLASS A | $589,000 | +17.3% | 5,736 | 0.0% | 0.04% | +27.3% | |
| CVS | CVS HEALTH CORPORATION | $569,000 | +21.6% | 5,519 | 0.0% | 0.04% | +32.3% | |
| WAT | WATERS CORPORATION | $572,000 | +4.2% | 1,536 | 0.0% | 0.04% | +13.9% | |
| ANTM | ANTHEM INC COM | $577,000 | +24.4% | 1,244 | 0.0% | 0.04% | +32.3% | |
| GSK | GLAXOSMITHKLINE PLC | $555,000 | +15.6% | 12,574 | 0.0% | 0.04% | +25.0% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $533,000 | +17.1% | 2,466 | 0.0% | 0.04% | +26.7% | |
| NVST | ENVISTA HOLDINGS CORP | $531,000 | +7.7% | 11,793 | 0.0% | 0.04% | +18.8% | |
| ABBV | ABBVIE | $506,000 | +25.6% | 3,740 | 0.0% | 0.04% | +33.3% | |
| BAX | BAXTER INTERNATIONAL INC | $509,000 | +6.7% | 5,929 | 0.0% | 0.04% | +16.1% | |
| ITGR | INTEGER HOLDINGS CORPORATION | $500,000 | -4.2% | 5,846 | 0.0% | 0.04% | +5.9% | |
| GILD | GILEAD SCIENCES INC | $487,000 | +4.1% | 6,705 | 0.0% | 0.04% | +12.9% | |
| HUM | HUMANA INC | $495,000 | +19.0% | 1,068 | 0.0% | 0.04% | +29.6% | |
| ICUI | ICU MEDICAL INC | $484,000 | +1.7% | 2,039 | 0.0% | 0.04% | +12.9% | |
| BDX | BECTON DICKINSON AND CO | $475,000 | +2.4% | 1,888 | 0.0% | 0.03% | +9.7% | |
| BMY | BRISTOL-MYERS SQUIBB CO | $452,000 | +5.4% | 7,256 | 0.0% | 0.03% | +14.3% | |
| HOLX | HOLOGIC INC | $447,000 | +3.7% | 5,845 | 0.0% | 0.03% | +14.3% | |
| CI | CIGNA CORPORATION | $446,000 | +14.7% | 1,943 | 0.0% | 0.03% | +23.1% | |
| NUVA | NUVASIVE INC | $412,000 | -12.3% | 7,850 | 0.0% | 0.03% | -3.2% | |
| PRGO | PERRIGO COMPANY | $382,000 | -17.8% | 9,823 | 0.0% | 0.03% | -12.9% | |
| JNJ | JOHNSON & JOHNSON | $370,000 | +6.0% | 2,161 | 0.0% | 0.03% | +13.0% | |
| TAK | TAKEDA PHARMACEUTICAL CO | $349,000 | -16.9% | 25,630 | 0.0% | 0.02% | -10.7% | |
| MCK | MCKESSON CORP | $335,000 | +25.0% | 1,346 | 0.0% | 0.02% | +33.3% | |
| SNY | SANOFI-SYNTHELABO | $333,000 | +3.7% | 6,650 | 0.0% | 0.02% | +14.3% | |
| UHS | UNIVERSAL HEALTH SERVICES INC CLASS B | $266,000 | -6.3% | 2,050 | 0.0% | 0.02% | 0.0% | |
| EBS | Exit | EMERGENT BIOSOLUTIONS INC | $0 | – | -4,294 | -100.0% | -0.01% | – |
| HRC | Exit | HILL ROM HOLDINGS | $0 | – | -4,346 | -100.0% | -0.04% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -51,848 | -100.0% | -0.11% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -620,887 | -100.0% | -0.35% | – |
| NVTA | Exit | INVITAE CORPORATION | $0 | – | -256,367 | -100.0% | -0.48% | – |
| WW | Exit | WW INTERNATIONAL INC | $0 | – | -458,273 | -100.0% | -0.55% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -4,128,443 | -100.0% | -0.59% | – | |
| STIM | Exit | NEURONETICS INC | $0 | – | -1,458,818 | -100.0% | -0.63% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -577,663 | -100.0% | -1.09% | – |
| XBI | Exit | SPDR S&P BIOTECH ETF | $0 | – | -204,600 | -100.0% | -1.70% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -2,985,712 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.